These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17445428)

  • 1. [The changes of esophageal epithelial intercellular spaces before and after omeprazole treatment in erosive esophagitis].
    Xue Y; Zhou LY; Lin SR
    Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):93-5. PubMed ID: 17445428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment.
    Xue Y; Zhou LY; Lin SR
    Chin Med J (Engl); 2008 Jul; 121(14):1297-301. PubMed ID: 18713551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Esophageal epithelial cells renewal in evaluation of the pariet efficacy in the treatment of patients with reflux esophagitis].
    Osadchuk MA; Lipatova TE; Chaplygin NV
    Eksp Klin Gastroenterol; 2002; (4):23-6, 131. PubMed ID: 12503269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytochrome P450 2C19 genetic polymorphisms in the therapeutic efficacy of omeprazole in Iranian patients with erosive reflux esophagitis.
    Zendehdel N; Biramijamal F; Hossein-Nezhad A; Zendehdel N; Sarie H; Doughaiemoghaddam M; Pourshams A
    Arch Iran Med; 2010 Sep; 13(5):406-12. PubMed ID: 20804307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of pungent dispersion bitter purgation method on the esophageal mucosal intercellular space of reflux esophagitis model rats].
    Tang YP; Liu SM; Wei W; Wei XD; Gong YX; Wang R; Li SH; Liu JW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Nov; 34(11):1335-41. PubMed ID: 25566625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of esophageal motility abnormalities in severe reflux esophagitis].
    Xu JY; Xie XP; Hou XH
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):353-5. PubMed ID: 16009005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regeneration of the esophagus epitheliocytes. Evaluation of pariet efficacy in the treatment of patients with reflux esophagitis].
    Osadchuk MA; Lipatova TE; Chaplygin NV
    Eksp Klin Gastroenterol; 2002; (2):43-6, 102. PubMed ID: 12046386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of omeprazole on symptoms and ultrastructural esophageal damage in acid bile reflux.
    Calabrese C; Fabbri A; Bortolotti M; Cenacchi G; Carlo S; Zahlane D; Miglioli M; Di Febo G
    World J Gastroenterol; 2005 Mar; 11(12):1876-80. PubMed ID: 15793885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group.
    Hassall E; Israel D; Shepherd R; Radke M; Dalväg A; Sköld B; Junghard O; Lundborg P
    J Pediatr; 2000 Dec; 137(6):800-7. PubMed ID: 11113836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose omeprazole for erosive esophagitis.
    Epling J; Taylor H
    J Fam Pract; 1999 Feb; 48(2):93-4. PubMed ID: 10037536
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical effect of proton pump inhibitors on reflux esophagitis].
    Sekiguchi T; Horikoshi T; Nishioka T; Kusano M
    Nihon Rinsho; 1992 Jan; 50(1):131-7. PubMed ID: 1311780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of conservative management of reflux esophagitis].
    Viani F; Dorta G
    Ther Umsch; 2001 Mar; 58(3):146-50. PubMed ID: 11305152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of eight weeks of rabeprazole therapy on nitric oxide plasma level and esophageal pH and motility and motility nitric oxide plasma level in patients with erosive esophagitis.
    Swiatkowski M; Budzyński J; Kłopocka M; Grad K; Pulkowski G; Augustyńska B; Suppan K; Fabisiak J
    Med Sci Monit; 2004 Feb; 10(2):CR46-51. PubMed ID: 14737042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.